NYU Langone Health researchers found that a type of cell death caused by a buildup of highly reactive molecules suppresses lung tumor growth.

Researchers at NYU said that an experimental drug that blocks a key protein can trigger a form of self-destruction in lung ...

Blocking the action in cancer cells of a key protein reduced by up to 80% tumor growth in mice with a common type of lung cancer.

ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to ...

Early-stage lung adenocarcinoma alters DNA methylation, mRNA transcription, and protein expression in adjacent tissues, exhibiting either steep changes at the tumor boundaries or shallow changes ...

Chemotherapy plus anti-PD-1 or anti-PD-L1 in advanced PD-L1–negative squamous cell lung carcinoma: A systematic review and meta-analysis. First-line camrelizumab plus chemotherapy in patients with ...

Lung adenocarcinoma remains one of the most challenging cancers to diagnose accurately, with pathologists spending countless hours examining tissue samples under microscopes to determine cancer grades ...

Lung cancer among nonsmokers is associated with germline risk factors, and EGFR/ALK-targeted therapies provide substantial ...

Bizengri received accelerated approval for NRG1 fusion-positive NSCLC and pancreatic adenocarcinoma, showing ORRs of 33% and 40%, respectively, with varying DORs. Imfinzi significantly improved ...